35,148 Shares in Encompass Health Corporation $EHC Bought by Acadian Asset Management LLC

Key Points

• Acadian Asset Management LLC purchased 35,148 shares of Encompass Health Corporation, amounting to approximately $3.56 million, during Q1.
• Encompass Health recently increased its quarterly dividend from $0.17 to $0.19 per share, showcasing the company's positive financial trajectory.
• Analyst ratings for Encompass Health have shifted positively, with eight analysts recommending a buy, reflecting growing confidence in the company's performance.

Acadian Asset Management LLC bought a new position in Encompass Health Corporation (NYSE:EHC - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 35,148 shares of the company's stock, valued at approximately $3,557,000.

Several other large investors have also made changes to their positions in the company. WPG Advisers LLC purchased a new position in Encompass Health in the first quarter valued at about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Encompass Health by 749.0% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company's stock valued at $42,000 after acquiring an additional 367 shares in the last quarter. Arlington Trust Co LLC grew its stake in Encompass Health by 22.9% in the first quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after purchasing an additional 125 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its stake in Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock worth $73,000 after purchasing an additional 115 shares in the last quarter. Finally, SVB Wealth LLC acquired a new position in Encompass Health in the first quarter worth about $84,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the company's stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares of the company's stock, valued at approximately $2,329,177.14. This represents a 5.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 2.10% of the company's stock.

Analyst Ratings Changes

A number of brokerages have commented on EHC. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a research note on Thursday, June 5th. Bank of America boosted their target price on Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a report on Wednesday, September 10th. UBS Group lifted their price target on shares of Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. KeyCorp lifted their price objective on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 27th. Finally, Truist Financial boosted their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a report on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company. According to MarketBeat.com, Encompass Health has an average rating of "Buy" and an average price target of $137.71.

Encompass Health Stock Down 0.6%

Shares of EHC opened at $126.04 on Monday. The firm has a market capitalization of $12.69 billion, a P/E ratio of 24.67, a P/E/G ratio of 2.20 and a beta of 0.92. The company has a 50-day simple moving average of $117.50 and a 200-day simple moving average of $112.94. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $127.15. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. The business had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The firm's revenue for the quarter was up 12.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.11 earnings per share. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, equities research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health's payout ratio is currently 13.31%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.